Retinol-Binding Protein 4 and New Adipocytokines in Nonalcoholic Fatty Liver Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|17|1921-1928

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.17, 2010-06, pp. : 1921-1928

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum Retinol-binding Protein 4 Levels in Patients with Diabetic Retinopathy

By Li Z-Z   Lu X-Z   Liu J-B   Chen L  

The Journal of International Medical Research, Vol. 38, Iss. 1, 2010-01 ,pp. : 95-99

Field House Publishing

Access to resources Recommend Favorite

Editorial [Hot topic: Adipocytokines in Nonalcoholic Fatty Liver Disease: Key Players Regulating Steatosis, Inflammation and Fibrosis (Executive Editor: Herbert Tilg)]

By  

Current Pharmaceutical Design, Vol. 16, Iss. 17, 2010-06 ,pp. : 1893-1895

Bentham Science Publishers

Access to resources Recommend Favorite

Nonalcoholic fatty liver disease: a review

By Poordad F Fred  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 3, 2005-08 ,pp. : 661-670

Informa Healthcare

Access to resources Recommend Favorite

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 14, 2014-04 ,pp. : 2403-2411

Bentham Science Publishers

Access to resources Recommend Favorite

Current treatment for nonalcoholic fatty liver disease

By Katsiki Niki   Athyros Vasilios G   Karagiannis Asterios   Mikhailidis Dimitri P  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 2141-2142

Informa Healthcare

Access to resources Recommend Favorite